» Articles » PMID: 34994908

Perineural Invasion is a Powerful Prognostic Factor for Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2022 Jan 7
PMID 34994908
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Taiwan has the highest incidence of upper tract urothelial carcinoma (UTUC) worldwide. Although many pathological factors can predict the prognosis of UTUC, previous studies have rarely discussed perineural invasion (PNI). Therefore, we aimed to investigate the effect of PNI on a well-established cohort of patients with UTUC.

Methods: This retrospective study included 803 patients with non-metastatic UTUC who underwent radical nephroureterectomy between June 2000 and August 2019. Demographic and clinicopathological parameters, including PNI, were collected for analysis. Using the Kaplan-Meier method and Cox proportional hazards model, we evaluated the significance of PNI with respect to progression-free survival (PFS), cancer-specific survival (CSS), and overall survival (OS).

Results: The median follow-up was 30.9 months, and there were 83 cases of PNI (10.3%). PNI-positive patients had unfavorable pathological features, including high pT stage, positive lymph node involvement, high tumor grade, and more lymphovascular invasion (all p < 0.001). Kaplan-Meier analysis showed that PNI was significantly associated with PFS, CSS, and OS (all p < 0.00001), and when combined with lymphovascular invasion, patients could be divided into groups with distinct survival rates (all p < 0.00001). In multivariate analysis, PNI was an independent factor leading to worse PFS (hazard ratio [HR] 1.72, 95% confidence interval [CI] 1.19-2.50; p = 0.004), CSS (HR 2.54, 95% CI 1.58-4.10; p = 0.0001), and OS (HR 1.78, 95% CI 1.19-2.65; p = 0.005).

Conclusions: We demonstrated an association between PNI and the prognosis of UTUC. Routine assessment of PNI in UTUC with standardized protocols may help achieve better risk stratification and subject selection for perioperative treatment.

Citing Articles

A new nomogram for predicting extraurothelial recurrence in patients with upper urinary tract urothelial carcinoma following radical nephroureterectomy.

Wu H, Jia D, Dai X, Cao H, Wang F, Yang T Front Oncol. 2024; 14:1442168.

PMID: 39568567 PMC: 11576284. DOI: 10.3389/fonc.2024.1442168.


Same Organ, Two Cancers: Complete Analysis of Renal Cell Carcinomas and Upper Tract Urothelial Carcinomas.

Vamesu S, Ursica O, Milea S, Deacu M, Aschie M, Mitroi A Medicina (Kaunas). 2024; 60(7).

PMID: 39064555 PMC: 11279004. DOI: 10.3390/medicina60071126.


Defining the role of multiparametric MRI in predicting prostate cancer extracapsular extension.

Sanguedolce F, Tedde A, Granados L, Hernandez J, Robalino J, Suquilanda E World J Urol. 2024; 42(1):37.

PMID: 38217693 PMC: 10787875. DOI: 10.1007/s00345-023-04720-5.


Lymph Node Dissection in Upper Tract Urothelial Carcinoma: Current Status and Future Perspectives.

Dlubak A, Karwacki J, Logon K, Tomecka P, Brawanska K, Krajewski W Curr Oncol Rep. 2023; 25(11):1327-1344.

PMID: 37801187 PMC: 10640513. DOI: 10.1007/s11912-023-01460-y.

References
1.
Roupret M, Babjuk M, Burger M, Capoun O, Cohen D, Comperat E . European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update. Eur Urol. 2020; 79(1):62-79. DOI: 10.1016/j.eururo.2020.05.042. View

2.
Liebig C, Ayala G, Wilks J, Berger D, Albo D . Perineural invasion in cancer: a review of the literature. Cancer. 2009; 115(15):3379-91. DOI: 10.1002/cncr.24396. View

3.
Amit M, Naara S, Gil Z . Mechanisms of cancer dissemination along nerves. Nat Rev Cancer. 2016; 16(6):399-408. DOI: 10.1038/nrc.2016.38. View

4.
Bakst R, Wong R . Mechanisms of Perineural Invasion. J Neurol Surg B Skull Base. 2016; 77(2):96-106. PMC: 4846411. DOI: 10.1055/s-0036-1571835. View

5.
De Franco L, Marrelli D, Voglino C, Vindigni C, Ferrara F, Di Mare G . Prognostic Value of Perineural Invasion in Resected Gastric Cancer Patients According to Lauren Histotype. Pathol Oncol Res. 2017; 24(2):393-400. DOI: 10.1007/s12253-017-0257-8. View